Health technology leader joins Verantos Strategic Advisory Board
Frank Williamsco-founder and president of Evolent Health, is a value-based health expert.
PALO ALTO, Calif., May 4, 2022 /PRNewswire/ — Verantosthe market leader in real-world, high-validity proof generation, recently announced the appointment of Frank Williams to its strategic council. Mr. Williams is chairman and co-founder of Evolent Health and previously served as the company’s CEO. Prior to founding Evolent, he was President and CEO of the Advisory Board Company, a research and technology company serving more than 5,000 healthcare organizations worldwide.
Considered a leader in the healthcare industry, Mr. Williams is known for his ability to drive meaningful change by challenging the status quo and creating a new path for companies at the forefront of precision medicine.
“The life sciences industry demands more credible real-world evidence and as a result, Verantos is growing rapidly,” said Dan Riskin, founder and CEO of the company. “Frank will help us refine our growth strategy while focusing on valid evidence. »
“I am delighted to join the Verantos Strategic Advisory Board at this critical time as their growth continues to accelerate,” confirmed Mr. Williams. “The company is well positioned to enable a learning healthcare system to dramatically improve patient care.”
Mr. Williams’ tenure on the Strategic Advisory Board began on March 1, 2022.
Verantos is the market leader in high-validity, real-world evidence across all life science therapeutic areas. By integrating strong clinical narrative data, artificial intelligence technology and measured validity, Verantos is the first company to generate research-grade evidence at scale. The Verantos RWE platform integrates heterogeneous real-world data sources and generates evidence with the precision needed for market access, medical affairs, and regulatory use.
E-mail: [email protected]